Skip to main content
. 2018 Feb 6;8(2):e019308. doi: 10.1136/bmjopen-2017-019308

Table 2.

Clinical presentations of patients who are HMPV positive

Diagnosis/symptom Total HMPV (n=101) Patients with only HMPV and HMPV plus other pathogen(s) detected.
Single HMPV (n=83) Copathogens (n=18) P value*
URTI
 Nasal obstruction 40 (39.6) 34 (41.0) 6 (33.3) 0.605
 Coryza 51 (50.5) 44 (53.0) 7 (38.9) 0.309
 Sneeze 1 (1.0) 1 (1.2) 0 (0) –†
 Cough 101(100) 83(100) 18(100) –‡
 Expectoration 78 (77.2) 66 (79.5) 12 (66.7) 0.351
 Hoarseness 1 (1.0) 1 (1.2) 0 (0) –†
LRTI
 Abnormal pulmonary breath sound§ 92 (91.1) 75 (90.4) 17 (94.4) 0.582
 Wheezing 47 (46.5) 40 (48.2) 7 (38.9) 0.473
 Anhelation 24 (23.8) 21 (25.3) 3 (16.7) 0.551
 Increasing lung markings¶ 6 (7.1) 4 (5.8) 2 (13.3) 0.304
 Bronchiolitis¶ 8 (9.5) 7 (10.1) 1 (6.7) 0.677
 Pneumonia¶ 11 (13.1) 10 (14.5) 1 (6.7) 0.415
 Bronchopneumonia¶ 56 (66.7) 46 (66.7) 10 (66.7) 0.626
Systemic influenza-like symptoms
 Fever (≥38˚C) 89 (88.1) 76 (91.6) 13 (72.2) 0.037
 Chill 7 (6.9) 6 (7.2) 1 (5.6) 0.8
 Debilitation 11 (10.9) 11 (13.3) 0 (0) –†
Gastrointestinal illness
 Vomiting 21 (20.8) 16 (19.3) 5 (27.8) 0.522
 Poor appetite 19 (18.8) 17 (20.5) 2 (11.1) 0.513
 Diarrhoea 7 (7.0) 3 (3.6) 4 (22.2) 0.018

Data are presented as n (%) of each group.

Percentages sum to >100% because some patients had more than one clinical presentations.

*Two-tailed χ2 test comparing the distribution of each illness or diagnosis between patients with only HMPV and HMPV plus other pathogen(s) detected.

†Not tested because the number of positive samples obtained was too small.

‡Not tested because the prevalence was 100%.

§Including phlegmatic, wheezing, bubbling and moist rales.

¶Diagnosed by chest radiography, and a total of 84 patients who are HMPV positive (69 patients with only HMPV detected and 15 patients with HMPV plus other pathogen(s) detected) were examined. HMPV, human metapneumovirus; LRTI, lower respiratory tract infection; URTI, upper respiratory tract infection.